21 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors in Hong Kong
424B5
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Prospectus supplement for primary offering
4:49pm
to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
Notice to Prospective Investors in Hong Kong
The shares
424B5
1va6z
27 Apr 23
Prospectus supplement for primary offering
7:06am
PRE 14A
tur sw13pd
14 Apr 23
Preliminary proxy
4:33pm
S-3
ihfxga
1 Jul 22
Shelf registration
5:06pm
DEF 14A
1wzdz
27 Apr 22
Definitive proxy
5:03pm
10-K
nvm59w9isqze79
28 Mar 22
Annual report
4:51pm
10-Q
7q6o hn0kuhto5k
16 Aug 21
Quarterly report
4:51pm
424B4
gxo9fxt9at7q
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.6
whl4vko3
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
xknsk9ol7 uxnhaea0
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.1
jsrciy070sny44wj0xcw
24 Jun 21
IPO registration (amended)
8:17am
S-1
EX-10.1
gls0x5q
9 Jun 21
IPO registration
5:02pm
S-1
m5jopbcqw5 4sie1s
9 Jun 21
IPO registration
5:02pm
DRS/A
EX-10.1
wch5h
3 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
nqyk0 9twb8vnnq
14 May 21
Draft registration statement (amended)
12:00am